These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 35924298)
1. Synthesis and evaluation of carbamate derivatives as fatty acid amide hydrolase and monoacylglycerol lipase inhibitors. Jaiswal S; Gupta G; Ayyannan SR Arch Pharm (Weinheim); 2022 Nov; 355(11):e2200081. PubMed ID: 35924298 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of dual fatty acid amide hydrolase-monoacylglycerol lipase inhibition and antinociceptive activities of 4-methylsulfonylaniline-derived semicarbazones. Jaiswal S; Akhilesh ; Uniyal A; Tiwari V; Raja Ayyannan S Bioorg Med Chem; 2022 Apr; 60():116698. PubMed ID: 35296453 [TBL] [Abstract][Full Text] [Related]
3. Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL). Korhonen J; Kuusisto A; van Bruchem J; Patel JZ; Laitinen T; Navia-Paldanius D; Laitinen JT; Savinainen JR; Parkkari T; Nevalainen TJ Bioorg Med Chem; 2014 Dec; 22(23):6694-6705. PubMed ID: 25282655 [TBL] [Abstract][Full Text] [Related]
4. Hexafluoroisopropyl Carbamates as Selective MAGL and Dual MAGL/FAAH Inhibitors: Biochemical and Physicochemical Properties. Barth M; Rudolph S; Kampschulze J; Meyer Zu Vilsendorf I; Hanekamp W; Mulac D; Langer K; Lehr M ChemMedChem; 2022 May; 17(9):e202100757. PubMed ID: 35072346 [TBL] [Abstract][Full Text] [Related]
5. Discovery of Isatin-Based Carbohydrazones as Potential Dual Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase. Jaiswal S; Ayyannan SR ChemMedChem; 2022 Jan; 17(1):e202100559. PubMed ID: 34637598 [TBL] [Abstract][Full Text] [Related]
6. (4-Phenoxyphenyl)tetrazolecarboxamides and related compounds as dual inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL). Holtfrerich A; Hanekamp W; Lehr M Eur J Med Chem; 2013 May; 63():64-75. PubMed ID: 23455058 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548 [TBL] [Abstract][Full Text] [Related]
8. A comparison of novel, selective fatty acid amide hydrolase (FAAH), monoacyglycerol lipase (MAGL) or dual FAAH/MAGL inhibitors to suppress acute and anticipatory nausea in rat models. Parker LA; Limebeer CL; Rock EM; Sticht MA; Ward J; Turvey G; Benchama O; Rajarshi G; Wood JT; Alapafuja SO; Makriyannis A Psychopharmacology (Berl); 2016 Jun; 233(12):2265-75. PubMed ID: 27048155 [TBL] [Abstract][Full Text] [Related]
9. New Disulfiram Derivatives as MAGL-Selective Inhibitors. Omran Z Molecules; 2021 May; 26(11):. PubMed ID: 34070869 [TBL] [Abstract][Full Text] [Related]
10. Potent dual MAGL/FAAH inhibitor AKU-005 engages endocannabinoids to diminish meningeal nociception implicated in migraine pain. Della Pietra A; Krivoshein G; Ivanov K; Giniatullina R; Jyrkkänen HK; Leinonen V; Lehtonen M; van den Maagdenberg AMJM; Savinainen J; Giniatullin R J Headache Pain; 2023 Apr; 24(1):38. PubMed ID: 37038131 [TBL] [Abstract][Full Text] [Related]
11. O-hydroxyacetamide carbamates as a highly potent and selective class of endocannabinoid hydrolase inhibitors. Niphakis MJ; Johnson DS; Ballard TE; Stiff C; Cravatt BF ACS Chem Neurosci; 2012 May; 3(5):418-26. PubMed ID: 22860211 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and in vitro evaluation of carbamate derivatives of 2-benzoxazolyl- and 2-benzothiazolyl-(3-hydroxyphenyl)-methanones as novel fatty acid amide hydrolase inhibitors. Myllymäki MJ; Saario SM; Kataja AO; Castillo-Melendez JA; Nevalainen T; Juvonen RO; Järvinen T; Koskinen AM J Med Chem; 2007 Aug; 50(17):4236-42. PubMed ID: 17665899 [TBL] [Abstract][Full Text] [Related]
13. Development and characterization of endocannabinoid hydrolases FAAH and MAGL inhibitors bearing a benzotriazol-1-yl carboxamide scaffold. Morera L; Labar G; Ortar G; Lambert DM Bioorg Med Chem; 2012 Nov; 20(21):6260-75. PubMed ID: 23036333 [TBL] [Abstract][Full Text] [Related]
14. Anticancer Potential of Small-Molecule Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase. Jaiswal S; Ayyannan SR ChemMedChem; 2021 Jul; 16(14):2172-2187. PubMed ID: 33834617 [TBL] [Abstract][Full Text] [Related]
15. Discriminative Stimulus Properties of the Endocannabinoid Catabolic Enzyme Inhibitor SA-57 in Mice. Owens RA; Ignatowska-Jankowska B; Mustafa M; Beardsley PM; Wiley JL; Jali A; Selley DE; Niphakis MJ; Cravatt BF; Lichtman AH J Pharmacol Exp Ther; 2016 Aug; 358(2):306-14. PubMed ID: 27307500 [TBL] [Abstract][Full Text] [Related]
16. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo. Long JZ; Nomura DK; Vann RE; Walentiny DM; Booker L; Jin X; Burston JJ; Sim-Selley LJ; Lichtman AH; Wiley JL; Cravatt BF Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20270-5. PubMed ID: 19918051 [TBL] [Abstract][Full Text] [Related]
17. Overview of the chemical families of fatty acid amide hydrolase and monoacylglycerol lipase inhibitors. Vandevoorde S Curr Top Med Chem; 2008; 8(3):247-67. PubMed ID: 18289091 [TBL] [Abstract][Full Text] [Related]
18. Metabolism of 2-acylglycerol in rabbit and human platelets. Involvement of monoacylglycerol lipase and fatty acid amide hydrolase. Gkini E; Anagnostopoulos D; Mavri-Vavayianni M; Siafaka-Kapadai A Platelets; 2009 Sep; 20(6):376-85. PubMed ID: 19811221 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol. Ghafouri N; Tiger G; Razdan RK; Mahadevan A; Pertwee RG; Martin BR; Fowler CJ Br J Pharmacol; 2004 Nov; 143(6):774-84. PubMed ID: 15492019 [TBL] [Abstract][Full Text] [Related]
20. 1,3,4-Oxadiazol-2-ones as fatty-acid amide hydrolase and monoacylglycerol lipase inhibitors: Synthesis, in vitro evaluation and insight into potency and selectivity determinants by molecular modelling. Käsnänen H; Minkkilä A; Taupila S; Patel JZ; Parkkari T; Lahtela-Kakkonen M; Saario SM; Nevalainen T; Poso A Eur J Pharm Sci; 2013 Jun; 49(3):423-33. PubMed ID: 23557840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]